Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells https://www.cell.com/cell/fulltext/S0092-8674(18)31322-9 NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines https://www.cell.com/cell/fulltext/S0092-8674(18)31381-3 I have posted two papers on the same topic, if someone wants to present one of them let me know LikeLike Reply
https://www.nature.com/articles/s41586-018-0812-9 Tissue-resident memory CD8+ T cells promote melanoma–immune equilibrium in skin LikeLike Reply
Regulatory T Cells Restrain Pathogenic T Helper Cells during Skin Inflammation https://www.cell.com/cell-reports/fulltext/S2211-1247(18)31923-5?dgcid=raven_jbs_etoc_email LikeLike Reply
klefalabjc.wordpress.com 
Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells
https://www.cell.com/cell/fulltext/S0092-8674(18)31322-9
NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines
https://www.cell.com/cell/fulltext/S0092-8674(18)31381-3
I have posted two papers on the same topic, if someone wants to present one of them let me know
LikeLike
https://www.nature.com/articles/s41586-018-0812-9
Tissue-resident memory CD8+ T cells promote melanoma–immune equilibrium in skin
LikeLike
Regulatory T Cells Restrain Pathogenic T Helper Cells during Skin Inflammation
https://www.cell.com/cell-reports/fulltext/S2211-1247(18)31923-5?dgcid=raven_jbs_etoc_email
LikeLike